Control Bionics (ASX:CBL)

📍 Surrey Hills, Australia🗓 Founded 2006👥 38 employees💰 Last funded Nov 2020
Control Bionics offers a suite of dedicated speech generating devices and AAC accessories to give people living with complex communication and physical needs their voice. Our product range is more intuitive and flexible than ever, giving users the power to make life-changing connections. Control Bionics makes NeuroNode, a sixth generation computer-human-interface (CHI) system that is designed to enable people with severe disabilities to communicate with their loved ones, carers, friends and the world at large with text, text-to-speech (TTS), instant messaging (IM), emails and the internet; and to control their own entertainment media (music, videos and online services) as well as expanding their own creativity with word processing, music and video editing, and design programs.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2006
Founded
Investor geography1 country
Singapore
1
Frequently asked questions
Who invested in Control Bionics (ASX:CBL)?
Control Bionics (ASX:CBL) has 1 investors on record on gritt.io.
When did Control Bionics (ASX:CBL) last raise funding?
The most recent investment in Control Bionics (ASX:CBL) recorded on gritt.io was in November 2020.
When was Control Bionics (ASX:CBL) founded?
Control Bionics (ASX:CBL) was founded in 2006.
What industry is Control Bionics (ASX:CBL) in?
Control Bionics (ASX:CBL) operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Control Bionics (ASX:CBL) based?
Control Bionics (ASX:CBL) is headquartered in Surrey Hills, Australia.